Difficulty: Medium
Average Score: 95%
Practice
A 58-year-old woman with a history of myasthenia gravis presents to the emergency department complaining of generalized abdominal pain. Her current medications include nifedipine and neostigmine. Her caretaker reports that her bottle of neostigmine is empty but was full earlier in the day. Which of the following findings is likely in this patient?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Constipation. Neostigmine is a cholinesterase inhibitor used to treat myasthenia gravis by increasing acetylcholine levels at the neuromuscular junction. In the gastrointestinal tract, increased acetylcholine levels can lead to increased smooth muscle tone and peristalsis, which can result in constipation.
Option A) Bronchodilation is incorrect because neostigmine does not have a direct effect on bronchial smooth muscle. Bronchodilation is associated with beta-2 adrenergic agonists like albuterol.
Option C) Dizziness is not a common side effect of neostigmine use. Dizziness is more commonly associated with anticholinergic medications that block acetylcholine receptors.
Option D) Hypotension is not expected with neostigmine use. Neostigmine can actually cause an increase in blood pressure due to its cholinergic effects.
Educationally, understanding the pharmacological effects of neostigmine is crucial for healthcare professionals managing patients with myasthenia gravis. It highlights the importance of monitoring for potential side effects like constipation due to increased cholinergic activity in the gastrointestinal tract. Healthcare providers need to be vigilant in recognizing and managing such adverse effects to provide optimal patient care.
Option A) Bronchodilation is incorrect because neostigmine does not have a direct effect on bronchial smooth muscle. Bronchodilation is associated with beta-2 adrenergic agonists like albuterol.
Option C) Dizziness is not a common side effect of neostigmine use. Dizziness is more commonly associated with anticholinergic medications that block acetylcholine receptors.
Option D) Hypotension is not expected with neostigmine use. Neostigmine can actually cause an increase in blood pressure due to its cholinergic effects.
Educationally, understanding the pharmacological effects of neostigmine is crucial for healthcare professionals managing patients with myasthenia gravis. It highlights the importance of monitoring for potential side effects like constipation due to increased cholinergic activity in the gastrointestinal tract. Healthcare providers need to be vigilant in recognizing and managing such adverse effects to provide optimal patient care.